We are a small, highly interactive and international research team whose passion is using new technological innovations to improve our understanding of metabolic (especially redox) processes in disease. We hope to use these findings to improve cancer patient survival, by finding routes to overcome drug resistance and eventually enabling earlier cancer detection. The cancer models we use range from single cells in petri dishes to intact living systems. Our imaging techniques use excitation wavelengths that span the electromagnetic spectrum, with a current focus on the near-infrared, and we are particularly interested in nanophotonic detection methods.